Key result
Erythroid elements express ACE protein across normal and disturbed haematopoiesis, supporting direct ACE inhibitor action.
Why the study?
A locally active renin-angiotensin system in bone marrow may regulate haematopoiesis, but the role of ACE expression in normal and diseased bone marrow was unclear.
Observational
Answers are grounded in this paper and cite their sources.
ACE expression by erythroid cells may explain ACE inhibitor effects on erythropoiesis; leaves open local RAS regulation of haematopoiesis.
It is proposed that a locally active, intrinsic renin-angiotensin system (RAS) exists in the bone marrow (BM) and plays a role in regulating haematopoiesis. Angiotensin II type I receptor has been detected on erythroid burst-forming unit-derived cells; its antagonist losartan and angiotensin I-converting enzyme (ACE) inhibitors can suppress erythropoiesis. The possible role of ACE/RAS in BM was investigated by evaluating ACE expression in normal BM, several myeloproliferative disorders and myelodysplasia. Immunohistochemical studies showed that erythroid elements expressed ACE protein in both normal and disturbed haematopoiesis. The presence of ACE in erythroid cells suggests another mechanism for direct ACE inhibitor activity in erythropoiesis.
No takes yet. Share an insight, caveat, or question.
Marušić-Vrsalović et al. (2003) conducted an observational in Normal bone marrow, myeloproliferative disorders, and myelodysplasia. ACE expression was evaluated on ACE protein expression on erythroid elements. Immunohistochemical studies demonstrated that erythroid elements expressed ACE protein in both normal and disturbed haematopoiesis, suggesting a direct mechanism for ACE inhibitor activity.
Synapse has enriched 10 related papers. Consider them for comparative context: